CA2304205A1 - Prevention des fausses-couches - Google Patents

Prevention des fausses-couches Download PDF

Info

Publication number
CA2304205A1
CA2304205A1 CA002304205A CA2304205A CA2304205A1 CA 2304205 A1 CA2304205 A1 CA 2304205A1 CA 002304205 A CA002304205 A CA 002304205A CA 2304205 A CA2304205 A CA 2304205A CA 2304205 A1 CA2304205 A1 CA 2304205A1
Authority
CA
Canada
Prior art keywords
fetuin
spermine
human
seq
pregnancy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002304205A
Other languages
English (en)
Inventor
Kevin J. Tracey
Haichao Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
North Shore Long Island Jewish Research Institute
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2304205A1 publication Critical patent/CA2304205A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pregnancy & Childbirth (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne un procédé permettant de prévenir les fausses couches pendant la grossesse. Ce procédé consiste à administrer une quantité efficace d'un polypeptide de fétuine.
CA002304205A 1997-09-18 1998-09-18 Prevention des fausses-couches Abandoned CA2304205A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/932,871 US6011005A (en) 1997-09-18 1997-09-18 Prevention of pregnancy miscarriages
US08/932,871 1997-09-18
PCT/US1998/019579 WO1999013897A1 (fr) 1997-09-18 1998-09-18 Prevention des fausses-couches

Publications (1)

Publication Number Publication Date
CA2304205A1 true CA2304205A1 (fr) 1999-03-25

Family

ID=25463092

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002304205A Abandoned CA2304205A1 (fr) 1997-09-18 1998-09-18 Prevention des fausses-couches

Country Status (6)

Country Link
US (2) US6011005A (fr)
EP (1) EP1015010A4 (fr)
JP (1) JP2001516726A (fr)
AU (1) AU731232B2 (fr)
CA (1) CA2304205A1 (fr)
WO (1) WO1999013897A1 (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6774227B1 (en) * 1993-05-17 2004-08-10 Cytokine Pharmasciences, Inc. Therapeutic uses of factors which inhibit or neutralize MIF activity
US6011005A (en) * 1997-09-18 2000-01-04 The Picower Institute For Medical Research Prevention of pregnancy miscarriages
US5994298A (en) * 1997-12-18 1999-11-30 Tsai; David Proteins for cancer cell specific induction of apoptosis and method for isolation thereof
US7186555B1 (en) * 1999-04-13 2007-03-06 The Feinstein Institute For Medical Research Prevention of brain damage in stroke
US8914114B2 (en) 2000-05-23 2014-12-16 The Feinstein Institute For Medical Research Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
BRPI0416591A (pt) * 2003-11-13 2007-01-30 Combinatorx Inc métodos e reagentes para o tratamento de distúrbios inflamatórios
EP1734941A2 (fr) 2004-03-25 2006-12-27 The Feinstein Institute for Medical Research Garrot neural
US10912712B2 (en) 2004-03-25 2021-02-09 The Feinstein Institutes For Medical Research Treatment of bleeding by non-invasive stimulation
US7329643B2 (en) * 2004-05-14 2008-02-12 The Feinstein Institute For Medical Research Inhibition of HMGB1 release by fetuin
WO2006073484A2 (fr) 2004-12-27 2006-07-13 North Shore-Long Island Jewish Research Institute Traitement de troubles inflammatoires par la stimulation electrique du nerf vague
US11207518B2 (en) 2004-12-27 2021-12-28 The Feinstein Institutes For Medical Research Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway
WO2009029614A1 (fr) 2007-08-27 2009-03-05 The Feinstein Institute For Medical Research Dispositifs et procédés permettant d'inhiber l'activation de granulocytes par stimulation neurale
US9662490B2 (en) 2008-03-31 2017-05-30 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug
WO2009146030A1 (fr) 2008-03-31 2009-12-03 The Feinstein Institute For Medical Research Méthodes et systèmes de réduction d’une inflammation par neuromodulation de l’activité des lymphocytes t
CN102215909B (zh) 2008-11-18 2014-09-10 赛博恩特医疗器械公司 优化用于消炎刺激的电极放置的装置和方法
US9211410B2 (en) 2009-05-01 2015-12-15 Setpoint Medical Corporation Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US8996116B2 (en) 2009-10-30 2015-03-31 Setpoint Medical Corporation Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction
EP2440284B1 (fr) 2009-06-09 2018-09-12 Setpoint Medical Corporation Manchon pour nerf muni d'une poche pour stimulateur sans fil
US11051744B2 (en) 2009-11-17 2021-07-06 Setpoint Medical Corporation Closed-loop vagus nerve stimulation
US9833621B2 (en) 2011-09-23 2017-12-05 Setpoint Medical Corporation Modulation of sirtuins by vagus nerve stimulation
CN102821814B (zh) 2009-12-23 2015-07-15 赛博恩特医疗器械公司 用于治疗慢性炎症的神经刺激设备和系统
WO2012154865A2 (fr) 2011-05-09 2012-11-15 Setpoint Medical Corporation Activation d'impulsions uniques de la voie anti-inflammatoire cholinergique pour traiter l'inflammation chronique
WO2013050453A1 (fr) 2011-10-07 2013-04-11 Baxter Healthcare S.A. Oxmif en tant que marqueur de diagnostic
US9572983B2 (en) 2012-03-26 2017-02-21 Setpoint Medical Corporation Devices and methods for modulation of bone erosion
JP6470178B2 (ja) * 2013-07-29 2019-02-13 株式会社プロトセラ 卵子の受精可能性の検査のためのバイオマーカーおよびそれを用いた判定
US11311725B2 (en) 2014-10-24 2022-04-26 Setpoint Medical Corporation Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
US11406833B2 (en) 2015-02-03 2022-08-09 Setpoint Medical Corporation Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator
US10596367B2 (en) 2016-01-13 2020-03-24 Setpoint Medical Corporation Systems and methods for establishing a nerve block
EP3405107B1 (fr) 2016-01-20 2023-04-12 Setpoint Medical Corporation Commande de stimulation vagale
WO2017127758A1 (fr) 2016-01-20 2017-07-27 Setpoint Medical Corporation Microstimulateurs implantables et systèmes de recharge par induction
US11471681B2 (en) 2016-01-20 2022-10-18 Setpoint Medical Corporation Batteryless implantable microstimulators
US10583304B2 (en) 2016-01-25 2020-03-10 Setpoint Medical Corporation Implantable neurostimulator having power control and thermal regulation and methods of use
US11173307B2 (en) 2017-08-14 2021-11-16 Setpoint Medical Corporation Vagus nerve stimulation pre-screening test
US11260229B2 (en) 2018-09-25 2022-03-01 The Feinstein Institutes For Medical Research Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
WO2021236977A1 (fr) 2020-05-21 2021-11-25 The Feinstein Institutes For Medical Research Systèmes et méthodes de stimulation du nerf vague

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011005A (en) * 1997-09-18 2000-01-04 The Picower Institute For Medical Research Prevention of pregnancy miscarriages

Also Published As

Publication number Publication date
JP2001516726A (ja) 2001-10-02
AU9320398A (en) 1999-04-05
AU731232B2 (en) 2001-03-29
EP1015010A4 (fr) 2004-09-15
US6117837A (en) 2000-09-12
EP1015010A1 (fr) 2000-07-05
WO1999013897A1 (fr) 1999-03-25
US6011005A (en) 2000-01-04

Similar Documents

Publication Publication Date Title
AU731232B2 (en) Prevention of pregnancy miscarriages
Labeta et al. Release from a human monocyte‐like cell line of two different soluble forms of the lipopolysaccharide receptor, CD14
Szekeres-Bartho et al. Progesterone-dependent immunomodulation
Satoh et al. Tissue inhibitor of metalloproteinases (TIMP-1) produced by granulosa and oviduct cells enhances in vitro development of bovine embryo
EP0833912B1 (fr) Nouvelle cytokine de type facteur de croissance transformant tgf-beta
AU631108B2 (en) Method to prepare a composition for treatment of amyotrophic lateral sclerosis
JP4804529B2 (ja) リンパ球化学誘引因子およびその用途
AU590543B2 (en) Purification of native colony stimulating factor-1
KR100424553B1 (ko) 사람인터루킨-6억제제
CA2020700A1 (fr) Composes pour l'inhibition de la formation d'une hormone proteinique et leurs utilisations
SATO et al. Production of Interleukin-1 α and a Parathyroid Hormone-Like Factor by a Squamous Cell Carcinoma of the Esophagus (EC-GI) Derived From a Patient With Hypercalcemia
EP0786002B1 (fr) Isoforme intracellulaire de l'antagoniste du recepteur de l'interleukine-1
US5256411A (en) Immune cell proliferation inhibitors
KR19980071708A (ko) 용골(溶骨)세포 형성 억제제
WO1989001946A1 (fr) Substances biologiques et procedes de production et d'utilisation de ces substances biologiques en therapeutique
CA2587061A1 (fr) Interferon beta desamine
Colten Biosynthesis of the MHC-linked complement proteins (C2, C4 and factor B) by mononuclear phagocytes
JPH06107693A (ja) 蛋白質とその蛋白質をコードするｄｎａ並びにその蛋白質の製造方法
Sarfati et al. T-cell-derived IgE-binding factors. II. Purification and characterization of IgE-binding factors produced by human T cell leukemia/lymphoma virus-1-transformed T lymphocytes.
EP0454765A1 (fr) Applications de proteines specifiques a la grossesse
JP2010537952A (ja) 過敏症反応の調節因子
EP0520834A2 (fr) Composition pharmaceutique pour le traitement des troubles du système immunitaire qui comprend PP14 ou des anticorps contre le PP14
KR20010043088A (ko) 신규인 폴리펩티드, 그 폴리펩티드를 코드화하는 ｃＤＮＡ및 그 용도
MILLER et al. Synthesis and glycosylation of proopiomelanocortin by a Cushing tumor
WO1991012334A1 (fr) Inhibiteur de l'activite des cytokines et applications de celui-ci

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued